News

GBRC signs MoU with Neuberg Supratech for coronavirus vaccine

As part of the five years agreement (effective May 1, 2020), Neuberg Supratech will work on two projects for the Government of Gujarat.

Read More

May 04, 2020

By : Team ABLE

We Now Need A Rapid Response To Economic Revival

India is enforcing one of the largest and strictest coronavirus lockdowns in the world and it is showing the desired results.

Read More

May 01, 2020

By : Kiran Mazumdar Shaw

DBT launches 1000 genome sequencing of SARS-Cov 2 Virus study

This study will sequence 1000 SARS Cov-2 genomes from the clinical samples to understand the evolving molecular phylogeny of the virus and the emerging mutations in the viral RNA

Read More

Apr 30, 2020

By : Team ABLE

Gilead announces results from phase 3 trial of investigational Remdesivir in patients with severe COVID-19

This study sought to determine whether a shorter, 5-day course of remdesivir would achieve similar efficacy results as the 10-day treatment regimen used in multiple ongoing studies of remdesivir.

Read More

Apr 30, 2020

By : Team ABLE

IIT Guwahati collaborates with Hester Biosciences to develop COVID-19 vaccine

IIT Guwahati and Hester Biosciences Limited expect the vaccine to be ready by the end of this year to start animal studies. The work is currently in its early stage of development.

Read More

Apr 29, 2020

By : Team ABLE

 

Archives

India Biotech Handbook 2024

Showcase your organization at BIO San Diego 2024

Focus Areas

Highlights